Australija - anglų - APVMA (Australian Pesticides and Veterinary Medicines Authority)

basf australia ltd. - fluxapyroxad - suspension concentrates for seed treatment (fs) - fluxapyroxad carboxamide active 333.0 g/l - fungicide

Australija - anglų - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - carbidopa monohydrate, quantity: 20.25 mg (equivalent: carbidopa, qty 18.75 mg); entacapone, quantity: 200 mg; levodopa, quantity: 75 mg - tablet, film coated - excipient ingredients: polysorbate 80; maize starch; hypromellose; croscarmellose sodium; iron oxide red; titanium dioxide; povidone; magnesium stearate; glycerol; mannitol; sucrose - l.c.e. sandoz 75/18.75/200 is indicated for the management of patients with parkinson's disease who are experiencing motor fluctuations.

Australija - anglų - APVMA (Australian Pesticides and Veterinary Medicines Authority)

bayer cropscience pty ltd - metalaxyl; penflufen; prothioconazole - suspension concentrates for seed treatment (fs) - metalaxyl phenylamide active 61.4 g/l; penflufen pyrazole active 38.4 g/l; prothioconazole triazole active 76.8 g/l - fungicide

Australija - anglų - APVMA (Australian Pesticides and Veterinary Medicines Authority)

imtrade australia pty ltd - abamectin; n-methylpyrrolidone; liquid hydrocarbon - emulsifiable concentrate - abamectin anthelmintic active 18.0 g/l; n-methylpyrrolidone solvent other 265.0 g/l; liquid hydrocarbon solvent other 58.0 g/l - miticide - apple | carnation | chrysanthemum or tanacetum | citrus | cotton | hops | indoor foliage plant | ornamental | pear | rose | stra - broad mite | brown citrus rust mite | carmine mite | citrus rust mite or maori mite | european red mite | native budworm or bollworm | tomato russet mite | brown citrus mite | carmine spider mite | citrus rust mites | heliothis | hemitarsonemus latus | native bollworm | red spider mite | rust mite | spider mite | tetranychus australis | tetranychus crataegi | tetranychus marilandica | tetranychus viennensis | tomato mite (47236) | two-spotted mite | two-spotted spider mite

Didžioji Britanija - anglų - myHealthbox

dr. reddy’s laboratories (uk) ltd., 6 riverview road - zoledronic acid (as monohydrate) - concentrate for solution for infusion - 4 mg for 5ml - drugs affecting bone structure and mineralization, bisphosphonates - it is used for prevention of skeletal related events (pathological fractures, spinal compression, radiation or surgery to bone, or tumour-induced hypercalcaemia) in adult patients with advanced malignancies involving bone. and for the treatment of adult patients with tumour-induced hypercalcaemia (tih)

Didžioji Britanija - anglų - myHealthbox

dr. reddy’s laboratories (uk) ltd - docetaxel - concentrate for solution for infusion (sterile concentrate) - 20mg/ml - taxanes - in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with: • operable node-positive breast cancer • operable node-negative breast cancer.

Australija - anglų - APVMA (Australian Pesticides and Veterinary Medicines Authority)

basf australia ltd. - clothianidin; imidacloprid - suspension concentrates for seed treatment (fs) - clothianidin ungrouped active 360.0 g/l; imidacloprid guanidine active 240.0 g/l - insecticide

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

lantheus medical imaging, inc. - fludeoxyglucose f-18 (unii: 0z5b2cjx4d) (fludeoxyglucose f-18 - unii:0z5b2cjx4d) - fludeoxyglucose f-18 200 mci in 1 ml - fludeoxyglucose f 18 injection is indicated for positron emission tomography (pet) imaging in the following settings: for assessment of abnormal glucose metabolism to assist in the evaluation of malignancy in patients with known or suspected abnormalities found by other testing modalities, or in patients with an existing diagnosis of cancer. for the identification of left ventricular myocardium with residual glucose metabolism and reversible loss of systolic function in patients with coronary artery disease and left ventricular dysfunction, when used together with myocardial perfusion imaging. for the identification of regions of abnormal glucose metabolism associated with foci of epileptic seizures. none risk summary data from published case series and case reports describe fludeoxyglucose f 18 injection crossing the placenta with uptake by the fetus (see data). all radiopharmaceuticals have the potential to cause fetal harm depending on the fetal stage of development and the magnitude of the radiation dose.

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

houston cyclotron partners lp dba cyclotope - sodium fluoride f-18 (unii: 9l75099x6r) (fluoride ion f-18 - unii:4m4we5n2ge) - fluoride ion f-18 200 mci in 1 ml - pregnancy category c any radiopharmaceutical including sodium fluoride f 18 injection has a potential to cause fetal harm. the likelihood of fetal harm depends on the stage of fetal development, and the radionuclide dose. animal reproductive and developmental toxicity studies have not been conducted with sodium fluoride f 18 injection. prior to the administration of sodium fluoride f 18 injection to women of childbearing potential, assess for presence of pregnancy. sodium fluoride f 18 injection should be given to a pregnant woman only if clearly needed. it is not known whether sodium fluoride f 18 injection is excreted into human milk. because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants, a decision should be made whether to interrupt nursing after administration of sodium fluoride f 18 injection or not to administer sodium fluoride f 18 injection, taking into account the importance of the drug to the mother. the body of scientific inform

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

university of north dakota - fludeoxyglucose f-18 (unii: 0z5b2cjx4d) (fludeoxyglucose f-18 - unii:0z5b2cjx4d) - fludeoxyglucose f-18 500 mci in 1 ml - fludeoxyglucose f 18 injection,usp is indicated in pet (positron emission tomography) for: 1. identification of regions of abnormal glucose metabolism associated with foci of epileptic seizures. 2. assessment of abnormal glucose metabolism to assist in the evaluation of malignancy in patients with known or suspected abnormalities found by other testing modalities, or in patients with an existing diagnosis of cancer. 3. assessment of patients with coronary artery disease and left ventricular dysfunction, when used together with myocardial perfusion imaging, for the identification of left ventricular myocardium with residual glucose metabolism and reversible loss of systolic function. fludeoxyglucose f 18 injection, usp is not indicated for distinguishing epileptogenic foci from brain tumors or other brain lesions which may cause seizures. none known